Related Experiment Video
Updated: Aug 18, 2026
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Expression of epidermal growth factor receptor in cervical tissue and serum in patients with cervical neoplasia
Seung Cheol Kim1, H-M Park, S-N Lee
1Department of Obstetrics and Gynecology, College of Medicine, Division of Molecular Biology, Ewha Medical Research Center, Ewha Women's University, Seoul, Korea. onco@ewha.ac.kr
Objective:
We hypothesized that there may be a relationship between epidermal growth factor receptor (EGFR) expression in cervical tissue and serum in patients with cervical neoplasia.
Materials And Methods:
The expression of EGFR was measured in cervical tissues from 23 cervical intraepithelial neoplasia patients and 16 cervical carcinoma patients using immunohistochemical staining and the level of serum EGFR extracellular domain was measured in serum from 17 cervical intraepithelial neoplasia patients and 14 cervical carcinoma patients using enzyme-linked immunosorbent assay.
Results:
The expression of EGFR was significantly increased as normal cervical tissue progressed to cervical intra-epithelial neoplasia then to cervical carcinoma (p = .009). The mean level of serum EGFR according to the intensity of immunohistochemical staining in negative, weakly positive, positive, and strongly positive staining was 19.36 +/- 3.12 fmol/mL, 20.99 +/- 3.59 fmol/mL, 29.08 +/- 16.86 fmol/mL, and 24.34 +/- 10.35 fmol/mL, respectively (p = .450).
Conclusions:
We believe that the level of serum EGFR may have a similar role as tumor markers such as the EGFR expression in cervical neoplastic tissue.
Related Concept Videos
02:38Mitogens and the Cell Cycle
01:19Clinical Applications of Epidermal Stem Cells